1. Home
  2. LYEL vs CION Comparison

LYEL vs CION Comparison

Compare LYEL & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$22.11

Market Cap

490.1M

Sector

Health Care

ML Signal

HOLD

CION

CION Investment Corporation

HOLD

Current Price

$8.15

Market Cap

464.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
CION
Founded
2018
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
490.1M
464.0M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
LYEL
CION
Price
$22.11
$8.15
Analyst Decision
Strong Buy
Sell
Analyst Count
3
1
Target Price
$25.00
$8.50
AVG Volume (30 Days)
95.9K
504.3K
Earning Date
01-01-0001
03-23-2026
Dividend Yield
N/A
14.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.55
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$7.73
52 Week High
$45.00
$12.57

Technical Indicators

Market Signals
Indicator
LYEL
CION
Relative Strength Index (RSI) 40.79 30.58
Support Level $21.27 N/A
Resistance Level $27.30 $9.50
Average True Range (ATR) 2.12 0.24
MACD 0.03 -0.02
Stochastic Oscillator 21.95 38.05

Price Performance

Historical Comparison
LYEL
CION

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

Share on Social Networks: